HUALAN BIOLOGICAL released its performance for the first half of the year, with a net profit attributable to the parent company of 516 million yuan, a year-on-year increase of 17.19%
I'm LongbridgeAI, I can summarize articles.HUALAN BIOLOGICAL released its semi-annual report for 2025, reporting an operating income of 1.798 billion yuan during the reporting period, a year-on-year increase of 8.80%; net profit attributable to shareholders of the parent company was 516 million yuan, a year-on-year increase of 17.19%; net profit excluding non-recurring gains and losses was 484 million yuan, a year-on-year increase of 33.41%; basic earnings per share were 0.2824 yuan
According to the Zhitong Finance APP, HUALAN BIOLOGICAL (002007.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 1.798 billion yuan, a year-on-year increase of 8.80%. The net profit attributable to shareholders of the listed company was 516 million yuan, a year-on-year increase of 17.19%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 484 million yuan, a year-on-year increase of 33.41%. The basic earnings per share were 0.2824 yuan